needle free injection systems
Post on 26-Mar-2015
121 Views
Preview:
TRANSCRIPT
Sree Datta Institute of Pharmacy 1
Needle Free Injection Systems
Prepared by Satish kumar K Guided by Ramakrishna Department of Industrial
Pharmacy
17 Feb 2011
Sree Datta Institute of Pharmacy 2
Contents
1. Introduction And History
2. Structure of Human Skin
3. The Injection Process: a Qualitative Description
4. Biomechanical Properties of Human Skin
5. Model Test Systems for Liquid Injectors
6. Advantages
7. Conclusion and References
17 Feb 2011
Sree Datta Institute of Pharmacy 3
Introduction
To overcome the problems related to needle based injections, there is one technology that has received constable attention during the past few years and that all of the sought after benefits is – Needle Free Injection Technology (NFIT) discovered in 19th century in France
Needle free technology offers the very obvious benefit of reducing patient concern about the use of needle
The main goal of this NFIT is to reduce patient phobia towards needle injection
This is mainly useful for the patients who are suffering from chronic diseases who require injectable products 2 or 3 times a day. For example : Diabetes patients
17 Feb 2011
Sree Datta Institute of Pharmacy 4
Needle Free History
In use since 1947– Military– International Public Health Campaigns
Widely used for mass immunizations and disease eradication.– Smallpox (1975)– Polio (when injected)– Measles (Brazil; 1990 to 1996)
17 Feb 2011
Sree Datta Institute of Pharmacy 5
Needle Free Requirements for the Developing World
Safety– Pathogen Transfer Issues– Disposal of Bio-Hazardous Material
Speed– High Thru-put
Ease of Use– Minimize training – Reduce repetitive motion injuries for health care workers– Simplify maintenance and spares logistics
Energy– Should be capable of being self powered
Cost– Must be comparable or less than traditional needle and
syringe on a per injection basis
17 Feb 2011
Sree Datta Institute of Pharmacy 6
Whole Skin Structure
17 Feb 2011
Sree Datta Institute of Pharmacy 7
The Epidermis I: Differentiating Keratinocytes
17 Feb 2011
stratum corneum corneocytes + lipid
stratum lucidum thin layer
stratum granulosum produces lipids
stratum spinosum numerous layers
start of differentiation stratum basale one layer cell division
Sree Datta Institute of Pharmacy 8
The Epidermis IIThe skin‘s diffusional barrier
17 Feb 2011
The skin‘s diffusional barrier
Sree Datta Institute of Pharmacy 9
Cells of the Dermis
Fibroblasts: produce fibres and ground substanceMast cells: around vessels = allergic responseMacrophages: phagacytosis
17 Feb 2011
Sree Datta Institute of Pharmacy 10
Fibres of the Dermis
The dermis‘ mechanical property
17 Feb 2011
Sree Datta Institute of Pharmacy 11
The Hypodermis (Subcutaneous Layer)
17 Feb 2011
Sree Datta Institute of Pharmacy 12
Description
The pharmacuetical sub assembly includes
Glass tube Pistons Nozzle made of standard materials Can be easily filled in on conventional filling lines
Recently Glide Pharma introduced a new model of needle free injection
17 Feb 2011
Sree Datta Institute of Pharmacy 1317 Feb 2011
Sree Datta Institute of Pharmacy 14
Mechanism
Needle free injection technology works by forcing liquid medication at high speed through a tiny orifice that is held against the skin
This creates an ultra stream of high pressure fluid that penetrates the skin without the use of needle
The design of this device has a majot influence on the accuracy of subcutaneous delivery and the stress imposed on the product to be delivered.
17 Feb 2011
Sree Datta Institute of Pharmacy 15
The design must ensure that a sufficiently high pressure is generated to puncture the skin, while the subsequent pressure is reduced to ensure that the molecule is deposited comfortably at a level that does not reach the muscle tissue
High pressure delivery could potentially fragile molecules, such as monoclonal antibodies.
Successful delivery of such molecules, therfore, requires a device with carefully controleed power nuances.
17 Feb 2011
Sree Datta Institute of Pharmacy 1617 Feb 2011
Sree Datta Institute of Pharmacy 17
The Injection Process: a Qualitative Description
(Needle & Needle-Free)
17 Feb 2011
Sree Datta Institute of Pharmacy 18
Comparison with Percutaneous Absorption
17 Feb 2011
Dissolved Drug
Diffusion
Partition: 21 kcc
Diffusion/Partitioning ProcessMajor diffusional barrier is stratum corneum
- morphology gives altered A* and l*- L lipid structure
Sree Datta Institute of Pharmacy 19
Needle/Needle-Free Injection
17 Feb 2011
NF- liquid
NF- powder
Needle
- Tissue penetration via needle or substance (fluid/particles) projected from needle-free device- puncture (mechanical failure) of epidermis & dermis- deformation of dermis/hypodermis
Sree Datta Institute of Pharmacy 20
Needle Free Technology
17 Feb 2011
How does It works?
Medication is driven at high speed
through a tiny orifice A fine stream of medication penetrates
the tissue Injection event requires less
than 0.5 seconds Injections can be IM, SC or ID
Sree Datta Institute of Pharmacy 21
Needle free dispersion patterns(Intra – Muscular)
Spherical bolus Amplified Dispersion
- Lowest possible - Very high
SA/V ratio SA/V ratio
- Limited tissue - Enhanced tissue
disruption disruption
17 Feb 2011
Sree Datta Institute of Pharmacy 22
Needle Free Technology What problems does it solve
- Avoids needle stick hazard
- No sharps disposal problems
- Eliminates the concern for the re-use of needles
- Injection pain is reduced in most cases
- Speeds the injection cycle
- Improved bio-availability of vaccines
- Reduces the system cost of injection
17 Feb 2011
Sree Datta Institute of Pharmacy 23
The Injection Process Viewed Qualitatively
Puncture & deformation of skin tissue is complex issue !
Requires knowledge of biomechanical properties ofskin tissue
Problem: biomechanical behaviour of skin isinhomogeneous, non-linear (depends on stress rate)& anisotropic
Skin layers (SC, E & D) have different biomechanical properties
- SC : high tensile strength, but thin - E/D: elastic & viscous behaviour (collagen & elastin
fibres, ground substance)
17 Feb 2011
Sree Datta Institute of Pharmacy 24
Needle-Free Injection Systems
Part 3: Biomechanical Properties of Human Skin
17 Feb 2011
Sree Datta Institute of Pharmacy 25
Biomechanical Properties of Skin:Measurement Techniques
How to measure biomechanical properties of humna skin?- Various experimental setups possible:
1. Stretching measurements in vitro & in vivo- stress versus strain
2. Compression measurements
3. Fracture resistance
4. Ultrasonic measurements
17 Feb 2011
Sree Datta Institute of Pharmacy 26
Biomechanical Properties of Skin:1. Stretching Experiments with Skin
Non-linearly elastic over whole stress range until yield
- stress-strain curve non-linear = elastin & collagen fibres
- large deformations before yield: ≥ 40 %
- highly viscoelastic (time dependent)
- anisotropic
- behaviour comes from dermis
- varies with age, sex, stress state, etc
17 Feb 2011
Sree Datta Institute of Pharmacy 27
Biomechanical Properties of Skin:2. Compression Experiments
Can apply up to 70 N force to skinMaximum deformation of 30 mm
17 Feb 2011
Sree Datta Institute of Pharmacy 28
Biomechanical Properties of Skin:3. Fracture Resistance Experiments
FR = energy required to separate a tissue sheet into 2 pieces [J/m2]
Interfacial fracture energy = f(work of adhesion, viscoelastic energy dissipation)
17 Feb 2011
Sree Datta Institute of Pharmacy 29
Biomechanical Properties of Skin:4. Ultrasonic Elasticity Measurement
17 Feb 2011
Sree Datta Institute of Pharmacy 30
Summary of Biomechanical Properties of Skin
Unique morphology defines the skin‘s mechanical properties
Stress/strain behaviour determined by dermis:
- linearly elastic over large low stress range E = 5 – 100 kPa
- similar compressibility as rubber = 0.49
- tensile strength very high above elastic limit (collagen)
17 Feb 2011
Sree Datta Institute of Pharmacy 31
Needle-Free Injection Systems
Part 6: Model Test Systems for Liquid Injectors
17 Feb 2011
Sree Datta Institute of Pharmacy 32
Needle-Free Injection of Liquid Epidermis Dermis Hypodermis
17 Feb 2011
High pressure liquid jet emerges from nozzle - 150 – 200 mm , - velocity 100 m/s - static pressure 10 MPa on skin surface®Liquid jet punctures skin tissues - forces related to needle penetration force®Liquid jet disperses in dermis(D) & hypodermis (HD) - force sufficient to overcome Young‘s modulus of D/HD (10 – 100 kPa) - dose volume small = assumption of linear elasticity
Sree Datta Institute of Pharmacy 33
Technologies
Mhi-500: Mhi-500 is a needle free insulin delivery system which
offers a a great benefit in diabetics care
Mhi-500 injects insulin by using a fine, high pressure jet of insulin.
This jet then penetrates the tissue, depositing the insulin In the subcutaneous layer.
This jet is created by forcing the insulin through a precisely designed nozzle that is held in contact with the tissue during the injection.
17 Feb 2011
Sree Datta Institute of Pharmacy 34
Recojet
Recojet is India’s first needle free insulin device and poised to revoultionize the insulin therapy
This is needle free insulin device mainly launched for injecting Recoinsulin (Recombinant human insulin).
17 Feb 2011
Sree Datta Institute of Pharmacy 35
Biojectwww.bioject.com
17 Feb 2011
pharmaject
Cool click
bio2000
Sree Datta Institute of Pharmacy 36
Bioject
Biojector 2000
Designed for the professional healthcare market
- Immunization programs
- Hospitals
- Clinics
Self InjectorsSpring powered
CO2 powered with electronics
17 Feb 2011
Sree Datta Institute of Pharmacy 37
Biojector injection capabilities
17 Feb 2011
Sree Datta Institute of Pharmacy 38
Other well known manufacturers are :
Powderject
Felton international
Glidepharma
17 Feb 2011
Sree Datta Institute of Pharmacy 39
Advantages It is trouble free, simple, self administration Low sensation and safety Solid dosage forms can be administered Elimination of needle phobia Minimal skin response and no bleeding or bruising Easy and safe disposal Easy to transport and store without refrigeration Excellent dose response is observed with increased drug
doses Rapid delivery of the drug to the systematic circulation Bio-equivalence has been demonstrated enabling the
development of ‘generic’ drug proteins
17 Feb 2011
Sree Datta Institute of Pharmacy 40
Conclusion Needle-free technology offers the very benefit of reducing
patient concern about conventional needles and no needle disposal issues.
Not only it can benefit the pharmacuetical industry in increasing product sales, it has the added potentioal to increase compliance with dosage regimens and improved outcomes.
In the developing world, there are major challenges of disease transmission through re-use of needles.
Organizations such as WHO and CDC (Center for Disease Control) and groups like Gates Foundation have supported the development of needle free alternatives for drug delivery.
17 Feb 2011
Sree Datta Institute of Pharmacy 41
The biotech revolution is bringing in a range of protein-based therapeutics into the market place at a rapid pace more than 300 products in active development.
These protein-based therapeutics especially monoclonal antibodies (Mabs) which are anticipated to represent 30 percent of pharmaceutical sales and which are otherwise challenging to deliver non-invasively, will continue to be formulated as injectables.
It is likely that dramatic change may occur only when a large pharmacuetical or biotechnology company adopts needle free technology and demonstrates its versatility, acceptance and value in major therapeutic area
17 Feb 2011
Sree Datta Institute of Pharmacy 42
References
Wikipedia
www.fda.gov
www.glidepharma.com
www.cdc.gov
www.bioject.com
17 Feb 2011
top related